Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma

With the advent of new targeted drugs in hematology and oncology patient prognosis is improved. Combination with antifungal prophylaxis challenges clinicians due to pharmacological profiles prone to drug–drug interactions (DDI). Midostaurin is a novel agent for FLT3-TKD/-ITD(mut)-acute myeloid leuke...

Descripción completa

Detalles Bibliográficos
Autores principales: Stemler, Jannik, Koehler, Philipp, Maurer, Christian, Müller, Carsten, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316674/
https://www.ncbi.nlm.nih.gov/pubmed/32514626
http://dx.doi.org/10.1007/s00277-020-04107-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316674/
https://www.ncbi.nlm.nih.gov/pubmed/32514626
http://dx.doi.org/10.1007/s00277-020-04107-1

Ejemplares similares